Trial Details
RecruitingBasic Information
| Clinical ID | c2492 |
|---|---|
| Identifier | NL-OMON20824 |
| Trial Title | Clinical Validation of a Point of Care (POC) Test for the Measurement of Infliximab (IFX) or Adalimumab (ADL) Levels in the Serum of Inflammatory Bowel Disease (IBD) Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | inflammatory bowel disease |
| Interventions | not applicable |
Participant Information
| Sponsor | ProciseDx |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Observational non invasive |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |